The present invention relates to processes for preparing certain piperidine derivatives, including fexofenadine (F), the active ingredient in the non-sedating antihistamine sold in the U.S. under the designation "Allegra.RTM.". This invention also relates to novel synthetic intermediates useful in the processes of the present invention.

 
Web www.patentalert.com

> Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1

~ 00358